USPTO serial 90730427
ALOQUEN
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- DETMER, CAROLYN ROSE
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with ALOQUEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kristen McCallion
Kristen McCallion FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MN 55440-1022United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Downloadable computer application software for managing, administering, and monitoring medication adherence; downloadable computer application software for monitoring patient behavior; downloadable computer software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; electronic downloadable publications in the nature of data files, findings in the nature of papers and reports, evaluations in the nature of papers and reports, and reports in the field of medicine and pharmacology | ACTIVE | — |
| 042 | Providing online non-downloadable software for managing, administering, and monitoring of medication adherence; providing online non-downloadable software for capturing, storing, processing, evaluating and reproducing medical and pharmaceutical data; software as a service (SAAS) services, featuring software for administering medication adherence programs, monitoring patient behavior, and enabling remote patient engagement to enable health care providers,clinical trial personnel, and clinical trial sponsors; providing online non-downloadable open source software for measuring patient behavior; platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in database management for use in drug development and analysis; platform as a service (PAAS) featuring computer software platforms using artificial intelligence for use in performing analysis of medical and pharmaceutical data and providing insights into that data; platform as a service (PAAS) featuring artificial intelligence for use in computer vision model development; platform as a service (PAAS) featuring artificial intelligence for self-service data analysis processing in the field of medicine and pharmacology | ACTIVE | — |
| 044 | Providing medical analysis services relating to the treatment of persons, namely, monitoring medication intake for purposes of analyzing medical treatment adherence; medical services being patient medication care management and medication adherence services, namely, communicating with patients regarding their medications and adherence to medication regimens for medical treatment and clinical research purposes; medication adherence programs, namely, interactive medical monitoring and alert service for reminding clients of medicinal dosage for medical treatment and clinical research purposes; providing medical information and medical monitoring information from remote locations via the Internet and telecommunication networks via patient monitoring devices that feed information to a website that can be accessed in real-time by medical professionals; providing a website featuring medical information in the nature of an online medical profile and medical record analysis service designed to provide patients and medical professionals with custom tailored information regarding medication adherence; medical services, namely, providing interactive medical monitoring and alert service for reminding patients of medication dosages and medication adherence for medical treatment and clinical research purposes | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by AICURE CORPORATION
- Other trademarks owned by AIC Innovations Group, Inc.
- Other trademarks owned by AIC Innovations Group, Inc.
- Other trademarks in Class 009
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named ALOQUEN
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jan 21, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Oct 14, 2025 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 14, 2025 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Sep 25, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 25, 2024 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Sep 25, 2024 | EXT4 | SOU EXTENSION 4 FILED | — |
| Sep 25, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 8, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 7, 2024 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 7, 2024 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 7, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 5, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 3, 2023 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 3, 2023 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 3, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 3, 2023 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 1, 2023 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 1, 2023 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 1, 2023 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 4, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 9, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 9, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 20, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 6, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 5, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 5, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 5, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 9, 2022 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2022 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 9, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 4, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 15, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Dec 15, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Dec 15, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Aug 19, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 27, 2021 | NWAP | NEW APPLICATION ENTERED | — |